# Syndax Pharmaceuticals Inc: Form DEF 14A, filed Apr 2, 2024

- Company: [Syndax Pharmaceuticals Inc](/companies/sndx.md) (CIK 1395937)
- Form: DEF 14A
- Filed: 2024-04-02
- Accepted by EDGAR: Apr 2, 2024, 16:00 ET
- Period: 2024-03-27
- Accession: 0000950170-24-040099
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1395937/000095017024040099/sndx-20240327.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1395937/000095017024040099/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1395937/000095017024040099/sndx-20240327.htm

Filed Apr 2, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-040099. Last ingested by Listed: Nov 2, 2026, 16:31 ET. No prices; not investment advice.